Actinogen Medical Limited (FRA:3AC)

Actinogen Medical Revenue

In the fiscal year ending June 30, 2025, Actinogen Medical had annual revenue of 5.49M AUD, down -44.73%. Actinogen Medical had revenue of 5.49M in the half year ending June 30, 2025, with 41.34% growth.

• Revenue: 5.49M AUD
• Revenue Growth: -44.73%
• P/S Ratio: 32.12
• Revenue / Employee: 914.93K AUD
• Employees: 6
• Market Cap: 98.42M EUR

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.49M	-4.44M	-44.73%
Jun 30, 2024	9.93M	5.04M	103.18%
Jun 30, 2023	4.89M	1.25M	34.28%
Jun 30, 2022	3.64M	1.66M	83.47%
Jun 30, 2021	1.98M	-1.53M	-43.58%